Empagliflozin improves HbA1c in young people with T2DM

For young people, empagliflozin is associated with improvement in glycated hemoglobin (HbA1c), according to a study published in the March issue of The Lancet Diabetes & Endocrinology.

Leave A Comment

Your email address will not be published. Required fields are marked *